Novo Nordisk A/S: Novo Nordisk’s operating profit decreased by 8% in Danish kroner and increased by 4% in local currencies in the first six months of 2018
Sales decreased by 5% in Danish kroner and increased by 4% in local currencies to DKK 54.3 billion. Sales of Victoza increased by 2% to DKK 11.7 billion (12% in local currencies). Sales of Saxenda…
FinanzNachrichten.de: Meistgelesene Nachrichten
